Engineering T cells directly inside the patient’s body to turn them into CAR-T cells ready to attack tumor cells, using…
en_news
Clarivate™ has revealed the annual list of Highly Cited Researchers™ 2025. This small fraction of the global researcher population contributes…
From November 6 to 7, 2025, VHIO hosted the first SOSCLC-AECC Annual Symposium at the “Pabellón Docente” of the Vall d’Hebron Campus. The event brought…
Marinada is a self-help group for women affected by breast cancer. Founded in 2005, the group has maintained a strong…
The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into…
The second edition of the VHIO Postdoc Day brought together the institute’s postdoctoral community to learn, reflect, and connect. Held…
On Sunday 19 October, the first “Run Against Cancer” race took place, organised by the ACSOSA Zona Nord association in…
Published in JAMA Oncology*, a consensus review article compiled by a group of renowned experts sets out recommendations for the…
Results from interim analysis of the international, multicenter, randomized phase III DESTINY-Breast09 study show that the combination of trastuzumab dertuxtecan…
At the recent European Society for Medical Oncology (ESMO) 2025 Congress held in Berlin, Dr. Marta Perachino, a researcher in…
